Skip to main content
TipRanks
Go Ultimate75% OFF

Robert W Postma Insider Profile

4 Followers

Robert W Postma, Director at Alaunos Therapeutics, holds 142.88K shares in Alaunos Therapeutics (Ticker: TCRT).

Robert W Postma's Trading History

TCRT
Alaunos Therapeutics
Oct 08, 2026DirectorUninformative Buy16.15K$228.60K
TCRT
Insider Shares: 142.88K (4.88%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 08, 2026Uninformative Buy$16.15K21,829$0.74―
Jul 27, 2026Uninformative Buy$16.25K8,463$1.92―
May 01, 2026Uninformative Buy$16.25K6,274$2.59―
Jan 15, 2026Uninformative Buy$16.25K5,622$2.89―
Nov 26, 2025Uninformative Buy$16.25K5,142$3.16―

You May Also Like

Robert W Postma insider profile FAQ

What is the percentage of profitable transactions made by Robert W Postma?
The percentage of profitable transactions made by Robert W Postma is 50%.
What is the average return per transaction made by Robert W Postma?
The average return per transaction made by Robert W Postma is -6.70%.
What stocks does Robert W Postma hold?
Robert W Postma holds: TCRT stocks.
What was Robert W Postma’s latest transaction?
Robert W Postma’s latest transaction was an Uninformative Buy of $16.15K.
What was Robert W Postma's most profitable transaction?
Robert W Postma’s most profitable transaction was an Informative Buy of TCRT stock on September 3, 2021. The return on the trade was 75.70%.
What is Robert W Postma's role in Alaunos Therapeutics?
Robert W Postma's role in Alaunos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.